- Supports the checklist structure by summarizing how providers, deployers, authorities, and post-market responsibilities interact after high-risk AI systems are on the market.
"providers have a post-market monitoring system in place"
Classify each AI system or model before choosing controls: scope, operator role, prohibited-practice screen, high-risk status, GPAI duties, transparency notices, monitoring, and incident handling.
This serves as an evidence checklist for product, legal, model-risk, engineering, privacy, security, procurement, and compliance teams working from official EU sources.
Structured answer sets in this page tree.
Cited legal and guidance references.
Start this EU AI Act checklist with scope and role, then branch by legal category. Prohibited practices stop the planned use; high-risk systems require technical, governance, conformity, and lifecycle evidence; GPAI model providers need model documentation, downstream information, copyright-policy evidence, and a public training-content summary; and Article 50 applies only to its specified interaction, marking, and disclosure cases. Add a date and legal-status field to every row. The original Article 5 prohibitions have applied since 2 February 2025 and most GPAI duties since 2 August 2025. Regulation (EU) 2026/1744, published on 24 July 2026 and entering into force on 27 July 2026, keeps 2 August 2026 as the general application date but applies Chapter III Sections 1-3 from 2 December 2027 for Annex III high-risk systems and from 2 August 2028 for Article 6(1) product-linked systems.
Create one checklist row per AI system, general-purpose AI model, or downstream product integration. The row should state whether the activity involves placing on the EU market, putting into service, using the system in the EU, or using output in the EU.
Record the role before assigning obligations. The AI Act distinguishes providers, deployers, importers, distributors, authorised representatives, product manufacturers, downstream providers, and affected persons. A company can hold more than one role for the same AI value chain.
Classify the checklist row before drafting controls. If a practice is prohibited, the practical answer is to stop, redesign, or escalate before deployment. If the system is high-risk, move to the high-risk evidence section. If it is limited-risk, check transparency obligations. If it is minimal-risk, keep the classification record and monitor for changes in purpose, data, users, or integration.
For Annex III systems, do not rely only on the sector label. Record the intended purpose, whether the system materially influences decision-making, whether profiling of natural persons is performed, and whether a narrow-task or preparatory-task exception is being claimed.
For each high-risk AI system, collect evidence before placing it on the market or putting it into service. The evidence pack should show that the provider can demonstrate compliance to a competent authority or notified body, and that deployers have the information needed to use and monitor the system appropriately.
When the system is already subject to sectoral product legislation, note whether AI Act evidence can be integrated into the existing product compliance, quality, or post-market files instead of creating a duplicate set.
For general-purpose AI models, keep a model-level record separate from downstream AI system records. Downstream teams need enough information to understand capabilities and limitations, while providers need their own technical documentation, copyright-policy evidence, and public training-content summary where Article 53 applies.
For GPAI models with systemic risk, add systemic-risk evaluation, mitigation, cybersecurity, and serious-incident records. Do not treat a downstream application review as a substitute for model-provider obligations.
Run transparency checks for both high-risk and non-high-risk AI systems. Article 50 duties are triggered by specific interactions and content types, so the checklist should identify the user-facing moment when information, marking, or disclosure must appear.
Keep the implementation evidence close to the product artifact: screenshots, UI copy, API fields, machine-readable marking approach, accessibility review, and the release version in which the notice or marker ships.
Close each checklist row only after it names the records that will be updated after release. High-risk systems need a documented post-market monitoring system and plan; deployers also need a path to inform providers and authorities when operation shows risk or a serious incident occurs.
Incident playbooks should separate high-risk AI system reporting from GPAI systemic-risk reporting, because the recipients and templates can differ.
Use these fields for the AI Act inventory and evidence table. They are designed to make each row reviewable while keeping confidential preparation artifacts and non-public company materials separate from published evidence references.
Reopen the row when the intended purpose changes, a GPAI model or supplier changes, the system enters a new Annex III use case, a transparency trigger is added, a serious incident occurs, or a competent authority, notified body, customer, or internal approver requests new evidence.
Use the cited sources listed here to verify obligations and the supporting evidence requirements.
Verify EU AI Act classification, high-risk controls, GPAI duties, transparency notices, and incident records using the cited sources on this page.
Review your AI inventory, role mapping, high-risk evidence, GPAI model records, transparency notices, and post-market monitoring gaps with Sorena.
"providers have a post-market monitoring system in place"
"serious incidents involving general-purpose AI models with systemic risk"
"marking and labelling of AI-generated content"
"only those making significant modifications need to comply"
"Template for the Public Summary of Training Content"
"provide that authority all the information and documentation necessary to demonstrate the conformity"